• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗反流手术或药物治疗无症状长节段 Barrett 食管患者的分子差异变化。

Differential molecular changes in patients with asymptomatic long-segment Barrett's esophagus treated by antireflux surgery or medical therapy.

机构信息

Department of Clinical Surgery, Trinity Centre for Health Sciences, St. James's Hospital and Trinity College Dublin, Dublin 8, Ireland.

出版信息

Am J Surg. 2010 Feb;199(2):137-43. doi: 10.1016/j.amjsurg.2008.11.032. Epub 2009 Mar 23.

DOI:10.1016/j.amjsurg.2008.11.032
PMID:19306979
Abstract

BACKGROUND

The Barrett's to adenocarcinoma sequence is characterized by molecular changes including activation of nuclear factor-kappaB (NF-kappaB) and related cytokines. In this observational nonrandomized study this molecular environment was compared in matched asymptomatic cohorts who had undergone either fundoplication or therapy with proton pump inhibitors (PPIs).

METHODS

Asymptomatic patients with long-segment Barrett's esophagus had endoscopic biopsy specimens taken from 2 cm below the squamocolumnar junction for measurement of activated NF-kappaB and a panel of cytokines and growth factors.

RESULTS

Thirty-seven patients were recruited (surgical: n = 18, medical: n = 19). The mean patient age was 51 years, and the mean follow-up period was 5.6 years. There were no differences in the length of Barrett's segment and endoscopic and histopathologic features in both groups. Mean activated NF-kappaB p50 and p65 subunits, interleukin (IL)-1alpha, IL-1beta, and interleukin-8 levels, were significantly (P < .05) lower in the surgically treated group.

CONCLUSIONS

This study provides proxy support to the thesis that antireflux surgery may provide an environment that is less inflammatory and tumorigenic than that observed in medically treated patients.

摘要

背景

巴雷特食管腺癌序列的特征是分子变化,包括核因子-κB(NF-κB)的激活和相关细胞因子。在这项观察性非随机研究中,我们比较了接受抗反流手术或质子泵抑制剂(PPIs)治疗的无症状患者的分子环境。

方法

对长节段巴雷特食管的无症状患者,从鳞柱状交界处下方 2cm 处取内镜活检标本,用于测量激活的 NF-κB 和一组细胞因子和生长因子。

结果

共招募了 37 名患者(手术组:n=18,药物组:n=19)。患者平均年龄为 51 岁,平均随访时间为 5.6 年。两组患者的巴雷特食管长度、内镜和组织病理学特征均无差异。手术组激活的 NF-κB p50 和 p65 亚单位、白细胞介素(IL)-1α、IL-1β 和白细胞介素-8 水平显著降低(P<.05)。

结论

这项研究为抗反流手术可能提供一种炎症和肿瘤发生程度低于药物治疗患者的环境这一观点提供了间接证据。

相似文献

1
Differential molecular changes in patients with asymptomatic long-segment Barrett's esophagus treated by antireflux surgery or medical therapy.抗反流手术或药物治疗无症状长节段 Barrett 食管患者的分子差异变化。
Am J Surg. 2010 Feb;199(2):137-43. doi: 10.1016/j.amjsurg.2008.11.032. Epub 2009 Mar 23.
2
Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.食管中炎症-化生-发育异常-腺癌序列中促炎细胞因子和核因子κB的表达
Am J Gastroenterol. 2005 Jun;100(6):1257-64. doi: 10.1111/j.1572-0241.2005.41338.x.
3
[The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].[巴雷特食管对胃食管反流病临床症状及术后结果的影响]
Zentralbl Chir. 2004 Apr;129(2):99-103. doi: 10.1055/s-2004-816278.
4
Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features.巴雷特食管在抗反流手术后能够且确实会消退:一项关于患病率和预测特征的研究。
J Am Coll Surg. 2003 May;196(5):706-12; discussion 712-3. doi: 10.1016/S1072-7515(03)00147-9.
5
Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis.手术抗反流手术能否降低巴雷特食管患者食管腺癌的发病率?一项荟萃分析。
Am J Gastroenterol. 2003 Nov;98(11):2390-4. doi: 10.1111/j.1572-0241.2003.08702.x.
6
Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery.抗反流手术后Barrett食管的长期临床和病理反应
Am J Surg. 2004 Jul;188(1):27-33. doi: 10.1016/j.amjsurg.2003.10.025.
7
Long-term follow-up of malignancy biomarkers in patients with Barrett's esophagus undergoing medical or surgical treatment.行内科或外科治疗的 Barrett 食管患者中恶性肿瘤标志物的长期随访。
Ann Surg. 2012 May;255(5):916-21. doi: 10.1097/SLA.0b013e31824e6c6a.
8
Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery.抗反流手术降低反流性食管炎和巴雷特食管中白细胞介素8基因的表达。
Arch Surg. 2007 Jun;142(6):554-9; discussion 559-60. doi: 10.1001/archsurg.142.6.554.
9
KTP laser ablation of Barrett's esophagus after anti-reflux surgery results in long-term loss of intestinal metaplasia. Potassium-titanyl-phosphate.抗反流手术后,用KTP激光消融巴雷特食管可导致肠化生长期消失。磷酸钛氧钾。
Surg Endosc. 2003 Jan;17(1):49-54. doi: 10.1007/s00464-001-8155-1. Epub 2002 Oct 8.
10
Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.质子泵抑制剂对巴雷特食管高级别异型增生和食管癌风险标志物的影响。
Aliment Pharmacol Ther. 2008 Feb 15;27(4):321-6. doi: 10.1111/j.1365-2036.2007.03579.x. Epub 2007 Nov 28.

引用本文的文献

1
Surgical treatment of GERD: systematic review and meta-analysis.胃食管反流病的手术治疗:系统评价和荟萃分析。
Surg Endosc. 2021 Aug;35(8):4095-4123. doi: 10.1007/s00464-021-08358-5. Epub 2021 Mar 2.
2
Antireflux surgery for dysplastic Barrett.发育异常的巴雷特食管的抗反流手术
World J Surg. 2015 Mar;39(3):588-94. doi: 10.1007/s00268-014-2632-x.
3
MicroRNA-196a & microRNA-101 expression in Barrett's oesophagus in patients with medically and surgically treated gastro-oesophageal reflux.接受药物和手术治疗的胃食管反流患者中,Barrett食管组织中MicroRNA - 196a和MicroRNA - 101的表达情况
BMC Res Notes. 2011 Feb 27;4:41. doi: 10.1186/1756-0500-4-41.
4
Long-term follow-up after anti-reflux surgery in patients with Barrett's esophagus.巴雷特食管患者抗反流手术后的长期随访。
J Gastrointest Surg. 2010 Oct;14(10):1483-91. doi: 10.1007/s11605-010-1322-8. Epub 2010 Sep 8.